Process for treatment and prevention of ventricular fibrillation
First Claim
Patent Images
1. The process for reducing the risk of ventricular fibrillation in an animal having a condition associated with ventricular fibrillation which comprises administering tyrosine to said animal in an amount effective to reduce the risk of ventricular fibrillation.
0 Assignments
0 Petitions
Accused Products
Abstract
The risk of ventricular fibrillation in animals is reduced by administering tyrosine, a tyrosine precursor, threonine or mixtures thereof, either alone or in combination with a substance which is known to reduce the risk of ventricular fibrillation. A novel composition is provided comprising a unit dosage form of tyrosine, a precursor for tyrosine, threonine or mixtures thereof and a substance which is known to reduce the risk of ventricular fibrillation.
-
Citations
2 Claims
- 1. The process for reducing the risk of ventricular fibrillation in an animal having a condition associated with ventricular fibrillation which comprises administering tyrosine to said animal in an amount effective to reduce the risk of ventricular fibrillation.
Specification
-
- Resources
Litigation Campaign Assessment
Thank you for your request. You will receive a custom alert email when the Litigation Campaign Assessment is available.
×
-
Current AssigneeMassachusetts Institute of Technology
-
Original AssigneeMassachusetts Institute of Technology
-
InventorsWurtman, Richard J., Lown, Bernard
-
Primary Examiner(s)Cacciapaglia, Jr., Frank
-
Application NumberUS06/122,422Time in Patent Office469 DaysField of Search424/319US Class Current514/567CPC Class CodesA61K 31/195 having an amino group
